Recent News

• 06.05.2025 - Jefferies Global Healthcare Conference
• 06.05.2025 - Jefferies Global Healthcare Conference
• 06.04.2025 - aTyr Pharma Announces Findings from Interim Analysis of Ongoing Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD)
• 06.04.2025 - aTyr Pharma Announces Findings from Interim Analysis of Ongoing Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD)
• 06.04.2025 - aTyr Pharma Announces Findings from Interim Analysis of Ongoing Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD)
• 05.28.2025 - Evercore Biotech Diamonds in the Rough Virtual Event
• 05.28.2025 - Evercore Biotech Diamonds in the Rough Virtual Event
• 05.27.2025 - Piper Sandler 3rd Annual Virtual Lung Symposium with ATS Takeaways
• 05.27.2025 - Piper Sandler 3rd Annual Virtual Lung Symposium with ATS Takeaways
• 05.27.2025 - Piper Sandler 3rd Annual Virtual Lung Symposium with ATS Takeaways

Recent Filings